Page last updated: 2024-08-16

ici 204,219 and 3-(((3-carboxycyclohexyl)amino)carbonyl)-4-(3-(4-(4-phenoxybutoxy)phenyl)propoxy)benzoic acid

ici 204,219 has been researched along with 3-(((3-carboxycyclohexyl)amino)carbonyl)-4-(3-(4-(4-phenoxybutoxy)phenyl)propoxy)benzoic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aratani, Y; Egashira, H; Fujita, M; Hisaichi, K; Ima, M; Imagawa, A; Inoue, A; Ishida, A; Itadani, S; Kadode, M; Kinoshita, A; Kitamine, T; Matsumura, N; Moriguchi, H; Nabe, T; Nakao, T; Nakayama, Y; Nomura, H; Ohmoto, K; Ohta, N; Sekiguchi, T; Sekioka, T; Tajima, Y; Takahashi, S; Takeuchi, J; Ueda, J; Yamaura, Y; Yashiro, K; Yonetomi, Y1
Chen, H; Nan, F; Wang, Z; Xie, X; Yang, H1

Other Studies

2 other study(ies) available for ici 204,219 and 3-(((3-carboxycyclohexyl)amino)carbonyl)-4-(3-(4-(4-phenoxybutoxy)phenyl)propoxy)benzoic acid

ArticleYear
Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.
    Journal of medicinal chemistry, 2015, Aug-13, Volume: 58, Issue:15

    Topics: Animals; Asthma; Biological Availability; Butyrates; Dogs; Guinea Pigs; Humans; Indoles; Leukotriene Antagonists; Rats; Receptors, Leukotriene

2015
Discovery of 3-Substituted 1H-Indole-2-carboxylic Acid Derivatives as a Novel Class of CysLT1 Selective Antagonists.
    ACS medicinal chemistry letters, 2016, Mar-10, Volume: 7, Issue:3

    Topics:

2016